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Summary
We describe the impact of two propeptides and PedC
on the production yield and the potency of recombi-
nant pediocins produced in Lactococcus lactis. On
the one hand, the sequences encoding the prope-
ptides SD or LEISSTCDA were inserted between the
sequence encoding the signal peptide of Usp45 and
the structural gene of the mature pediocin PA-1. On
the other hand, the putative thiol-disulfide oxido-
reductase PedC was coexpressed with pediocin. The
concentration of recombinant pediocins produced in
supernatants was determined by enzyme-linked
immunosorbent assay. The potency of recombinant
pediocins was investigated by measuring the minimal
inhibitory concentration by agar well diffusion assay.
The results show that propeptides SD or LEISSTCDA
lead to an improved secretion of recombinant
pediocins with apparently no effect on the antibacte-
rial potency and that PedC increases the potency of
recombinant pediocin. To our knowledge, this study
reveals for the first time that pediocin tolerates
fusions at the N-terminal end. Furthermore, it reveals
that only expressing the pediocin structural gene in a
heterologous host is not sufficient to get an optimal
potency and requires the accessory protein PedC. In
addition, it can be speculated that PedC catalyses the
correct formation of disulfide bonds in pediocin.
Introduction
Bacteriocins from lactic acid bacteria are defined as
antimicrobial proteinaceous compounds synthesized by
ribosomes (Riley, 2009). They are used in food as bio-
preservatives and were lately suggested as drug candi-
dates and probiotic promoting factors (Dobson et al.,
2012). As bio-preservatives, they can be added to food
following three different strategies: in situ into fermented
food by bacterial culture which constitutes the starter
culture, directly in a purified or semi-purified form (e.g.
nisin A, nisaplin, Danisco) and as an ingredient based on
a fermentation of a bacteriocin-producing strain (pediocin
PA-1, ALTA 2431, Quest International) (Cotter et al.,
2013). Utilization of bacteriocins as drugs in human or
veterinary health has also been considered (Cotter et al.,
2013; Van Heel et al., 2011). The industrial use of
bacteriocins requires efficient downstream and upstream
processes. However, low production rate by natural bac-
terial producers can dramatically impair further application
of bacteriocins (Jack et al., 1996; Guyonnet et al., 2000;
Jasniewski et al., 2008).
Heterologous expression is an efficient strategy to
enhance bacteriocin production yields. The lactic acid bac-
terium Lactococcus lactis was successfully used to
produce bacteriocins (Rodríguez et al., 2003) including
pediocin PA-1 (Horn et al., 1998; 1999; 2004; Reviriego
et al., 2005; 2007a,b; Martín et al., 2007a; Arqués et al.,
2008), and could therefore be used as a host for large-
scale production. Besides, due to its generally recognized
as safe status, L. lactis is an interesting bacterium for in
vivo delivery of bacteriocins for probiotic purpose
(Osmanagaoglu et al., 2010; Pontes et al., 2011; Dobson
et al., 2012) or in fermented food (Renye and Somkuti,
2010). Another strategy, which aims at improving the
secretion step and thereby the overall productivity, is to
replace the wild-type signal peptide of the recombinant
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protein by the Usp45 signal peptide (SPusp45), thus
allowing secretion of pediocin PA-1 through the secretory
pathway (Li et al., 2011). However, although recombinant
pediocin PA-1 was successfully produced, little attention
has been paid to the fact that the positive charges of
pediocin PA-1 might impair secretion through the secretory
pathway. Indeed, the study of recombinant protein produc-
tion in L. lactis showed that the insertion of the peptide
LEISSTCDA between the signal peptide and the recombi-
nant protein NucB allowed to increase production of NucB
from 3 mg/L to 15 mg/L, highlighting the importance of the
nature of the amino acids localized immediately after the
cleavage site of the signal peptidase (Le Loir et al., 1998;
Pontes et al., 2011). The class IIa bacteriocin divercin
RV41 was successfully secreted through the secretory
pathway with the remaining propeptide SD fused to the
bacteriocin at the N-terminus after the cleavage site. This
propeptide SD results from the cloning procedure in the
NsiI restriction site that allows translational fusion between
SPusp45 and the coding sequence of interest (Bermúdez-
Humarán et al., 2007). As previously suggested (Morello
et al., 2008), it could be expected that the negative charge
of aspartate in the propeptide SD might enhance protein
secretion. However, this point, as well as the impact of the
propeptide SD on the divercin RV41 specific activity, has
not been investigated.
Pediocin PA-1 is a model class IIa bacteriocin produced
by several strains from Pediococcus and Lactobacillus
species. This bacteriocin exhibits antibacterial activity
against a wide spectrum of food-borne pathogens and
food spoilage gram-positive bacteria (Rodríguez et al.,
2002). As other class IIa bacteriocins, it affects both mem-
brane permeability and membrane potential (Rodríguez
et al., 2002). Mature pediocin PA-1 is a 44 amino acid
peptide containing four cysteine residues involved in two
disulfide bonds (Henderson et al., 1992). The pediocin
PA-1 operon consists of the four genes named pedA,
pedB, pedC and pedD, which encode the prepediocin
PA-1, the pediocin PA-1 immunity protein, an accessory
export protein and an ABC transporter (involved in the
excision of the signal peptide and the secretion of
pediocin) respectively (Venema et al., 1995).
The aim of this work was to investigate the efficiency
of heterologous production of pediocin in Lactococcus
lactis at the quantitative and the qualitative levels with a
special focus on protein secretion and post-translational
modification.
Results
Impact of propeptides on secretion efficiency
The three plasmids pSec::rpedA, pSec::s-rpedA and
pSec::l-rpedA were constructed with the aim to produce
three different recombinant pediocins (Fig. 1). The three
plasmids contain chimeras where spusp45, which encodes
the signal peptide of Usp45, was fused to the mature
pediocin encoding sequence ΔsppedA. In the plasmid
pSec::rpedA, spusp45 was directly fused to ΔsppedA which
theoretically leads, after cleavage by the signal peptidase,
to the release of a recombinant pediocin (Rpediocin)
exhibiting the primary structure of the wild-type mature
pediocin PA-1. In the plasmids pSec::s-rped and pSec::l-
rped, the sequences encoding the propeptides SD and
LEISSTCDA, respectively, were inserted between spusp45
and Δsp::pedA. These plasmids theoretically lead to the
secretion of recombinant fusion pediocins PA-1, named
S-Rpediocin and L-Rpediocin, that would exhibit the
peptide SD and LEISSTCDA at the N-terminus respec-
tively. The three plasmids were used to transform L. lactis,
and the resulting strains were cultivated in order to
produce the expected recombinant pediocins. The strain
L. lactis NZ9000_pSec::nucB was used as control. This
control strain produces an extracellular staphylococcal
nuclease (NucB) with no known antibacterial property.
For each producer, a dry weight of 0.7 g/L was meas-
ured, indicating that all strains approximately produced the
same biomass. Furthermore, the maximum specific growth
rate (0.8 h−1) was not significantly different between
strains. The concentration of each recombinant pediocin
was measured by Enzyme-Linked Immunosorbent Assay
(ELISA), and the specific production was determined by
normalizing pediocin PA-1 concentration to dry weight
bacteria (Table 1). The strain L. lactis NZ9000_pSec::
rpedA produced approximately 2.3 ± 0.4 μmol/g of recom-
binant pediocin, while the wild-type producer strain
Lactobacillus plantarum LMAX exhibited a specific prod-
uctivity below 0.1 μmol/g. This result shows that specific
production of recombinant pediocin by L. lactis is approxi-
mately 20 times more efficient than production of pediocin
by the wild-type strain. Subsequently, ELISA experiments
revealed that the strains L. lactis NZ9000_pSec::s-rped
and L. lactis NZ9000_pSec::l-rped produced approxi-
mately 3.5 ± 0.2 and 3.2 ± 0.3 μmol/g of pediocin respec-
tively. The results thus show that the SD and LEISSTCDA
propeptides allow a 1.5-fold increase in secreted recombi-
nant pediocin production.
Antibacterial activity
The antibacterial activity of supernatants was assessed
by agar-well diffusion assay using Carnobacterium
maltaromaticum DSM20730_pSec::nucB_pOri23 as
target strain. Inhibition areas were obtained from the
culture supernatants of the three strains L. lactis
NZ9000_pSec::rpedA, L. lactis NZ9000_pSec::s-rpedA
and L. lactis NZ9000_pSec::l-rpedA (Fig. 2A, panels 2, 3
and 4). No inhibition was obtained with the culture super-
natant of the control strain L. lactis NZ9000_ pSec::nucB
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(Fig. 2A, panel 1). Moreover, no inhibition was observed
when the same experiment was carried out with an indica-
tor strain previously transformed with pOri::pedB, which
confers immunity to pediocin PA-1 (Fig. 2B, panels 2, 3
and 4). These results show the three strains L. lactis
NZ9000_pSec::s-rpedA, L. lactis NZ9000_pSec::l-rpedA
and L. lactis NZ9000_pSec::rpedA produce active recom-
binant pediocins. The supernatants containing the recom-
binant pediocins Rpediocin, S-Rpediocin and L-Rpediocin
exhibited minimal inhibitory concentration (MIC) values of
1.5 ± 0.3 μM, 1.2 ± 0.1 μM and 1.2 ± 0.2 μM (Table 1)
respectively. These results show the propeptides SD and
LEISSTCDA have no major impact on the MIC value of the
supernatants containing recombinant pediocins.
Co-production of PedC with S-Rpediocin
The potency of the recombinant pediocins produced in
L. lactis was compared with the wild-type pediocin pro-
duced by Pediococcus acidilactici. Surprisingly, the wild-
type pediocin PA-1 produced from P. acidilactici exhibited
a MIC value of 0.05 μM, and was thus approximately
30 times more active than the recombinant pediocins.
This result suggests that the structure of recombinant
pediocins is different from the wild-type pediocin (Fig. 3).
Although class IIa bacteriocins are described to be non-
post-translationally modified, they all exhibit at least one
disulfide bond. It was previously described that disulfide
bonds are important for the antibacterial activity of
pediocin PA-1 (Fimland et al., 2000). Even if disulfide
bond formation can be spontaneous, this is a slow and
aspecific process that can require enzymatic catalysis in
bacteria (Kadokura et al., 2003). It was hypothesized that
such enzymes could allow correct formation of disulfide
bonds in wild-type pediocin PA-1 bacterial producers
(Fimland et al., 2000). Lately, it was shown that thiol-
disulfide oxidoreductases (TDORs), which belong to the
thioredoxin superfamily and are characterized by a con-
served CXXC motif, are involved in the post-translational
maturation of the bacteriocins sublancin 168 and BlpGst
(Dorenbos et al., 2002; Fontaine and Hols, 2008).
Interestingly, sequence analysis of the pediocin PA-1
operon pedABCD revealed that pedC encodes a putative
secreted protein with a CXXC motif and a thioredoxin-like
fold. It can be therefore hypothesized that PedC is a
TDOR and allows native disulfide bond formation of
pediocin PA-1.
The encoding sequence of pedC was cloned into
pOri23, and the resulting plasmid was used to transform
L. lactis NZ9000_pSec::s-rpedA. In parallel, the same
recipient strain was transformed with pOri23, and the
resulting strain was used as a control strain. Inhibition
assays resulted in broader growth inhibition halos for the
strain transformed with pOri::pedC (Fig. 4A) than for the
strain transformed with pOri23 (Fig. 4C). Consistently,
the MIC value of the recombinant pediocin decreased
from 1.2 ± 0.1 μM to 0.4 ± 0.1 μM when pedC was
co-expressed with the recombinant pediocin (Table 1).
Table 1. Specific production and antimicrobial activity.
Strain Specific productiona,b MICa,c
L. lactis NZ9000_pSec::rpedA 2.3 ± 0.4 1.5 ± 0.3
L. lactis NZ9000_pSec::s-rpedA 3.5 ± 0.2d 1.2 ± 0.1
L. lactis NZ9000_pSec::l-rpedA 3.2 ± 0,3d 1.2 ± 0.2
L. lactis NZ9000_pSec::s-rpedA_pOri23 4.0 ± 0,7 1.3 ± 0.5
L. lactis NZ9000_pSec::s-rpedA_pOri::pedC 1.4 ± 0.1e 0.4 ± 0.1
a. Mean ± standard deviation.
b. Specific production was expressed as μmol pediocin PA-1 equivalents/g of dry weight bacteria.
c. MIC values of culture supernatants were expressed in μM pediocin PA-1 equivalents.
d. Indicate a significant difference (Student’s t-test, P-value < 0,05) of specific production between the strains L. lactis NZ9000_
pSec::s-rpedA L. lactis NZ9000_pSec::l-rpedA and the control strain L. lactis NZ9000_pSec::rpedA.
e. Indicate a significant difference (Student’s t-test, P-value < 0,05) of specific production between the strains L. lactis NZ9000_
pSec::s-rpedA_pOri::pedC and the control strain L. lactis NZ9000_pSec::s-rpedA_pOri::pedC.
Fig. 2. Antibacterial activity of recombinant pediocins. The antibac-
terial activity of recombinant pediocins was assessed on agar plate
using the sensitive strain C. maltaromaticum
DSM20730_pSec::nucB_pOri23 (line A) or the pediocin PA-1 resist-
ant strain C. maltaromaticum DSM20730_pSec::nucB_pOri::pedB
(line B) as target strains. Pictures in columns 1, 2, 3, 4 show the
inhibitory activity of the culture supernatants of the negative control
(heterologous production of NucB from Staphylococcus aureus),
Rpediocin (recombinant mature pediocin PA-1), S-Rpediocin
(recombinant pediocins PA-1 fused to the peptide SD at the
N-terminus) and L-Rpediocin (recombinant pediocins PA-1 fused to
the peptide LEISSTCDA at the N-terminus) respectively.
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Besides, the strain producing PedC exhibited a three
times lower specific productivity compared with the control
strain (Table 1). These results show that even if lower
amounts of recombinant pediocin are produced, a higher
activity was obtained with strain co-producing the recom-
binant pediocin and PedC. When the same experiment
was carried out with the indicator strain transformed with
the pOri::pedB plasmid, which encodes the pediocin PA-1
immunity factor, no inhibition was observed (Fig. 2B and
D). Furthermore, no inhibition was observed when the
control strain L. lactis NZ9000_pSec::nucB was trans-
formed with pOri::pedC, indicating that PedC does not
exhibit detectable antibacterial activity in our experimental
conditions (data not shown). These results show that
PedC allows increasing the antibacterial potency of the
recombinant pediocin S-Rpediocin in L. lactis.
PedC homologues as putative antibacterial activity
promoting factors of bacteriocins
Previous studies already showed that the TDORs BlpGst
and BdbA are involved in disulfide bond formation of the
bacteriocin thermophilin 13 (Fontaine and Hols, 2008)
and the bacteriocin sublancin 168 (Dorenbos et al., 2002)
respectively. BLASTP analysis revealed that BlpGst
shares 26% of identity (e-value = 2,00E-008) with PedC,
and that BdbA shares 17% of identity (e-value = 4,00E-
008) with PedC. Furthermore, BlpGst and PedC both
exhibit a thioredoxin-like fold (Interproscan accession
number IPR012336), a CXXC motif and a bacteriocin
transport accessory protein-like fold (Interproscan acces-
sion number IPR005985). The proteins SkgC, PlaC,
CoaC which are transport accessory proteins of the class
IIa bacteriocins sakacin G, plantaricin 423 and coagulin
A (Fig. 5), respectively, appears to have the same
thioredoxin-like fold and the same bacteriocin transport
accessory protein-like fold as PedC. Moreover, PedC
shares 47% (e-value = 1,00E-056), 99% (e-value =
1,00E-132) and 99% (e-value = 3,00E-132) of identity
with SkgC, PlaC and CoaC respectively. This suggests
that SkgC, PlaC and CoaC might enhance the activity of
Fig. 3. Strategies used to quantitatively and qualitatively act on pediocin production in L lactis. Two propeptides were tested to improve secre-
tion, and PedC was coexpressed with recombinant pediocin to improve its potency.
Fig. 4. The antimicrobial activity of recombinant pediocin produced
by L. lactis NZ9000_pSec::s-rped_pOri::pedC (line A and line B)
and L. lactis NZ9000_pSec::s-rped_pOri23 (line C and line D) was
assessed on agar plate using the sensitive strain
C. maltaromaticum DSM20730_pSec::nucB_pOri23 (line A and C)
or the pediocin PA-1 resistant strain C. maltaromaticum
DSM20730_pSec::nucB_pOri::pedB as target strains (line B and
D). Picture in lines A and C show serial twofold dilutions of culture
supernatants of strains L. lactis NZ9000_pSec::s-rpedA_pOri::pedC
and L. lactis NZ9000_pSec::s-rpedA_pOri23 respectively. The con-
centrations below the pictures are expressed in μM equivalents of
pediocin PA-1.
ª 2015 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology, Microbial
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the class IIa bacteriocins sakacin G, plantaricin 423 and
coagulin A respectively.
Discussion
The general secretion (Sec) system of L. lactis was
widely used to improve secretion of recombinant proteins
including bacteriocins (Herranz and Driessen, 2005;
Bermúdez-Humarán et al., 2007; Borrero et al., 2011a,b;
Jiménez et al., 2013) such as the bacteriocin pediocin
PA-1 (Martín et al., 2007a; Li et al., 2011). In order to allow
secretion via the Sec system in L. lactis, the signal
peptide of the Usp45 protein SPusp45 is commonly fused to
the N-terminus of recombinant proteins (Morello et al.,
2008). Since it is thought that positive charges impair
secretion through the secretory pathway, sequences
encoding SD or LEISSTCDA propeptides were fused to
the nucleotide sequence encoding the mature pediocin
PA-1 (ΔsppedA) at the 5′ end. Both propeptides allowed
the improvement of the production of recombinant
pediocins with no marked difference between propeptides
SD and LEISSTCDA.
The effect of the signal peptide SPusp45 and the
propeptide LEISSTCDA were previously described to
improve the overall productivity in L. lactis (Le Loir et al.,
1998; 2001; Langella and Le Loir, 1999; Freitas et al.,
2005; Nouaille et al., 2005; Zhang et al., 2010). The
replacement of the signal peptide of NucB by the signal
peptide of the major secreted protein Usp45 (SPusp45)
increased NucB secretion. It was hypothesized that
enhancement of protein secretion resulted from a more
efficient recognition of the SPusp45 by the secretory secre-
tion machinery of L. lactis. Moreover, when the propeptide
LEISSTCDA was inserted between SPusp45 and NucB,
secretion was further improved. The underlying mecha-
nism is still unknown, it is speculated that the negative
charges of the propeptide LEISSTCDA would increase
the cleavage efficiency by signal peptidase and/or would
fold into a conformational state that would lead to optimal
secretion efficiency. This optimal secretion efficiency
would therefore allow the protein precursor to be less
sensitive to intracellular degradation or would help to
escape intracellular degradation thus increasing the pro-
duction yield (Le Loir et al., 2005). A similar mechanism
could explain the higher productivity of the recombinant
pediocins fused to SD or LEISTCDA propeptides.
Propeptides SD and LEISSTCDA did not have any sig-
nificant impact on the antibacterial specific activity of
recombinant pediocin PA-1. Thorough analysis of the
impact of additional amino acid residues on specific activ-
ity of sakacin P revealed that an extra lysine residue at
the C-terminal end had no marked effect on antibac-
terial activity. However, a lysine residue added at the
N-terminus strongly reduced the potency of sakacin P
(Kazazic et al., 2002). These results indicate that adding
amino acid residues at the N-terminal end of class IIa
bacteriocins can have various impacts on their potency
and peptide engineering implying peptide fusion at the
N-terminus would require checking the impact on antibac-
terial potency of pediocin-like bacteriocins.
It was shown that all recombinant pediocins in the
culture supernatants, including Rpediocin, are less
active than the wild-type pediocin PA-1 produced by
P. acidilactici. Similar results were already reported for
pediocin PA-1, enterocin A, divercin RV41 and sakacin A,
and it was hypothesized that recombinant bacteriocins
might be subjected to self-aggregation, degradation or
could be misfolded (Bermúdez-Humarán et al., 2007;
Martín et al., 2007a,b; Borrero et al., 2011b; Jiménez
et al., 2013). Another hypothesis would be linked to the
fact that pediocin PA-1 has two disulfide bonds. The
disulfide bond at the N-terminus is conserved in class IIa
bacteriocins, whereas the disulfide bond at the
C-terminus is less conserved and is important for both
pediocin PA-1 spectrum and stabilization inside the bac-
terial membrane (Fimland et al., 1996; 2000; 2005). When
heterologous production of pediocin PA-1 is performed
using Lactobacillus sakei, non-native disulfide bonds are
formed (Fimland et al., 2000). We hypothesized that
similar cystein mispairing were formed in recombinant
pediocin PA-1 produced in L. lactis. Sequence analysis of
the pedABCD operon revealed pedC would encode a
protein with a putative thioredoxin fold and a CXXC cata-
lytic site, suggesting a probable role in the status of the
pediocin PA-1 disulfide bonds. In this study, co-production
of PedC and the recombinant pediocin S-Rpediocin led to
the production of a bacteriocin with higher potency.
Although PedC is described as an accessory transport
Fig. 5. Genetic structure of gene clusters of class IIa bacteriocin containing a pedC homologue.
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protein, it was indeed concluded to be essential for secre-
tion by the dedicated secretion system in both Pediococci
and Escherichia coli (Venema et al., 1995). Nevertheless,
since the amount of pediocin PA-1 produced was not
measured, it remains unclear whether the absence of
activity recorded in this study was due to a decrease of
secretion efficiency and/or of potency. In line with this,
another study demonstrated that PedD was sufficient to
allow secretion of pediocin PA-1 in E. coli (Bukhtiyarova
et al., 1994). Our results further support that PedC
increases the potency of pediocin PA-1. Sequence analy-
ses showed that pedC homologous genes are genetically
linked to genes encoding the class IIa bacteriocin sakacin
G, plantaricin 423 and coagulin A suggesting that TDORs
are critical functions for these bacteriocins. Two other
studies revealed the role of TDORs in the potency of
bacteriocins belonging to other classes: the class VI
sublancin 168 (Dorenbos et al., 2002) and the class IIb
thermophilin 9 (Fontaine and Hols, 2008), suggesting that
the role of TDORs in the potency of bacteriocins would be
not restricted to one particular class of bacteriocins.
When PedC was co-expressed with recombinant
pediocin S-Rpediocin, a lower concentration of S-
Rpediocin was obtained in the culture supernatant.
Sequence analysis of PedC suggested it contains a
secretory-dependent signal peptide. In addition, pedC is
under the control of the strong constitutive promoter p23
(Van der Vossen et al., 1987). Therefore, it can be specu-
lated that PedC competes with the recombinant pediocin
for the recruitment by the secretory machinery for
secretion.
This study revealed that the model class IIa bacteriocin
pediocin PA-1 is sufficiently flexible to tolerate fusions at
the N-terminal end. This property was used here to
improve secretion efficiency and could also be used for
other purposes such as genetic engineering of innovative
antibacterial compounds as previously shown for other
bacteriocins (Qiu et al., 2003; Acuña et al., 2012). More-
over, this work revealed that solely expressing the struc-
tural gene of class IIa pediocin PA-1 in a heterologous
host may not be sufficient to get an optimal antibacterial
activity, and that PedC might be helpful to enhance the
activity of recombinant bacteriocins, probably by increas-
ing the concentration of correct disulfide bond containing
peptides. Furthermore, these results suggest that the
protein PedC is responsible for the formation of disulfide
bonds in pediocin PA-1 in the wild-type context.
Experimental procedures
Bacterial strains, culture conditions and plasmids
Bacterial strains and plasmids used in this study are listed in
Table 2. Lactococcus lactis NZ9000 was grown at 30°C in
M17 (Difco, Sparks, USA) supplemented with 1% (w/v)
glucose (GM17 medium). Carnobacterium maltaromaticum
DSM20730 was grown in Trypton Salt Broth medium (TSB;
Biomérieux, Marcy-l’Étoile, France) supplemented with 6 g/L
yeast extract (TSBYE) at 30°C. Lactobacillus plantarum
LMAX, which was isolated from HOLDBAC Listeria
(Danisco), was grown in Man, Rogosa and Sharpes medium
(MRS, Biokar, Beauvais, France) at 30°C. Lactococcus lactis
NZ9000 transformants were grown in GM17 containing
10 μg/ml chloramphenicol or/and 10 μg/ml erythromycin
(Sigma-Aldrich, Saint-Louis, USA). Carnobacterium malta-
romaticum DSM20730 transformants were grown in
TSBYE containing 5 μg/ml chloramphenicol or/and 5 μg/ml of
erythromycin.
Electroporation
Electrocompetent L. lactis NZ9000 was obtained as previ-
ously described (Holo and Nes, 1989). For electrocompetent
C. maltaromaticum, an overnight culture was diluted 10-fold
in fresh TSBYE medium and incubated at 30°C until an
OD600 nm of 0.7 was reached. Then bacteria were harvested
by centrifugation at 6000 g for 15 min. Following three
washes in ice-cold 10% glycerol solution, the pellet was
re-suspended in 1 ml of the same washing solution and
stored at –80°C. The electric pulse was delivered with a
Gene-Pulser (Bio-Rad Laboratories, Richmond, USA.) set up
at 25 μF, 2.1 kV and 200 Ω. Then, the suspension was mixed
with 4 ml of TSBYE and incubated 4 h at 30°C prior plating on
selective medium containing 5 μg/ml chloramphenicol or/and
5 μg/ml erythromycin.
Plasmid construction
All the polymerase chain reaction (PCR) products used for
cloning purpose were obtained with the oligonucleotide
primers (Eurogentec, Seraing, Belgique) described in Table 3
by using the high-fidelity thermostable polymerase Pfx50
(Invitrogen, Carlsbad, USA). The expression vectors pSec::s-
rpedA and pSec::l-rpedA were constructed by using
pSec::nucB as recipient vector. Polymerase chain reaction
product PCRSD and PCRLEI (Table 2) were digested with
NsiI and EcoRI (New England Biolabs, Massachusetts,
Ipswich, USA) and were ligated into the pSec expression
vector previously digested with the same enzymes to gener-
ate pSec::s-rpedA and pSec::l-rpedA expression vectors
respectively. The plasmid pSec::rpedA was constructed by
deleting the SD encoding sequence by crossover PCR. To do
so, the PCR products named PEDA1 and PEDA2 which flank
the SD encoding region, were obtained by using pSec::s-
rpedA as DNA matrix. The product named PEDA3 was
obtained by crossover PCR by using PEDA1 and PEDA2 as
DNA matrix and was subsequently digested with BglII and
XhoI and cloned into the pSec expression vector previously
digested with the same enzymes in order to generate the
expression vector pSec::rpedA. Plasmid pOri::pedC was
obtained by digesting the PCR product PEDC with BamHI
and PstI (FastDigest, Thermo Fisher Scientific, Waltham,
Massachusetts, USA). The plasmid pOri::pedB was con-
structed similarly by using the primers described in Table 3.
All the recombinant plasmids were obtained by using the
ligation mixes to electrotransform L. lactis NZ9000. The integ-
ª 2015 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology, Microbial
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rity of plasmid inserts was checked by DNA sequencing
according to the method of Sanger (GATC-BIOTECH,
Konstanz, Germany).
Heterologous expression
For strains containing pSec::nucB or pSec derivatives, a
culture incubated for 17 h was used to inoculate 200 ml of
GM17 supplemented with chloramphenicol (10 μg/ml) in a
250 ml flask at an initial OD600 nm of 0.02. Cultures were grown
at 100 r.p.m. stirring (Amplitude: 20 mm; Sanyo, Osaka,
Japan) and at 30°C. For strains containing both pSec::nucB
or derivatives, and pOri23 or derivatives, a culture incubated
for 17 h was used to inoculate 200 ml of GM17 medium
supplemented with chloramphenicol (2 μg/ml) and eryth-
romicyn (2 μg/ml) in a 250 ml flask at an initial OD600 nm of 0.1.
For all strains, heterologous production was induced with
100 ng/ml of semi-purified nisin (balance sodium chloride and
denatured milk solids containing 2.5% of nisin from Sigma-
Aldrich, St Louis, USA) when OD600 nm reached 0.4–0.5. After
24 h of incubation, cell dry weights were determined
gravimetrically. Then the supernatants were collected after
centrifugation (5000 g; 15 min). Each supernatant was neu-
tralized with 6M NaOH, sterilized by microfiltration (0.2 μm)
and stored at −20°C. The experiments were independently
performed three times.
ELISA
Recombinant pediocin concentrations were measured
by ELISA. Rabbit serum containing anti-pediocin PA-1
polyclonal antibodies was purchased from Eurogentec
(Seraing, Belgique). Goat anti-rabbit IgG antibodies coupled
with Horseradish peroxidase (HRP) were purchased from
Sigma-Aldrich (St Louis, USA). Between each step described
below, the microtitre plate was washed eight times with
washing buffer (phosphate buffer saline containing 0.05% of
Tween 20). Microtitre plate wells (Corning, New york, USA)
were coated overnight at 4°C with 200 μl of filtered culture
supernatant containing recombinant pediocins previously
diluted with phosphate buffer saline (PBS) when required.
Wells were subsequently blocked with 300 μl of skimmed
milk (10% w/v in PBS, Régilait, Saint-Martin-Belle-Roche,
France) for 1 h at room temperature. Wells were then incu-
bated with 150 μl of anti-pediocin polyclonal antibodies
(1:1000 in PBS) for 1 h at room temperature, followed by
incubation with 100 μl of HRP-labelled goat anti-rabbit IgG
(1:2000 in PBS) for 1 h. Bound secondary antibodies were
detected by adding 100 μl of 3,3′,5,5′-tetramethylbenzidine
(TMB, Thermo Fisher Scientific, Waltham, USA). The reac-
tion was stopped with 100 μl of 2M H2SO4 and absorbance
was read at 450 nm. Concentration of recombinant pediocins
in the supernatants were extrapolated from a calibration
curve constructed using purified pediocin PA-1 from P.
acidilactici (Sigma-Aldrich, St Louis, USA) diluted with PBS
and were expressed in μM equivalents of pediocin PA-1.
Antimicrobial assay
Minimal inhibitory concentration of pediocin PA-1 and recom-
binant pediocins were determined by well diffusion assay on
agar plates (Mathieu et al., 1993) by using the strain
C. maltaromaticum DSM20730_pSec_pOri23 as indicator.
Minimal inhibitory concentration is defined as the lowest con-
centration exhibiting a distinct inhibition zone after 24 h at
30°C.
Sequence analysis
The nucleotide sequence of putative thiol disulfide
oxidoreductases were analysed using BLAST (Altschul et al.,
1997), SIGNALP (Nielsen et al., 1997), CONSERVED DOMAIN
DATABASE CDD (Marchler-Bauer and Bryant, 2004;
Marchler-Bauer et al., 2007; 2013) and INTERPROSCAN
(Quevillon et al., 2005). The amino acid sequence of PedC
(accession number: P37249), BdbA (accession number:
P68569), SkgC (accession number: B2LS01 ), CoaC (acces-
sion number: Q9EZB1), PlaC (accession number: Q93FV5),
BlpGst (accession number: Q03J39) used for analysis are
from UNIPROT.
Table 3. Primers and PCR products.
PCR product
name Matrix Primersa
PEDB Lb. plantarum LMAX Forward : ATCGGGATCCTAAAAAGGGAGGCCAAATATAATGAATAAGACTAAGTCGGAA
Reverse : ATCGCTGCAGCTATTGGCTAGGCCACGT
PCRSD sd::ΔsppedA Forward : CCCCCCCCATGCATCTGATAAATATTATGGTAATGGAGTTACTTGTGGA
Reverse : CCCCCCGAATTCACTAGTCCTTAACATTTATGATTACCTTG
PCRLEI leisstcda::ΔsppedA Forward : CCCCCCCCATGCATTAGAAATTTCATCAACATGTGATGCTAAATAT
Reverse : CCCCCCGAATTCACTAGTCCTTAACATTTATGATTACCTTG
PEDA1 pSec::s-rpedA Forward : ACAGCTCCAAGATCTAGTCTT
Reverse : AGTAACTCCATTACCATAATATTTTGCATAAACACCTGACAACGG
PEDA2 pSec::s-rpedA Forward : CCGTTGTCAGGTGTTTATGCAAAATATTATGGTAATGGAGTTACT
Reverse : ACATGCTGAAGAGCATCTCATT
PEDA3 PEDA1 and PEDA2 Forward : ACAGCTCCAAGATCTAGTCTT
Reverse : ACATGCTGAAGAGCATCTCATT
PEDC Lb. plantarum LMAX Forward : GGGGGGGGATCCTAAAAAGGGAGGCCAAATATAATGTCTAAGAAATTTTGGTCAAA
Reverse : GGGGGGCTGCAGCTACTGATTATTGTAATCAGC
a. Restriction sites are in bold, Ribosome Binding Site sequences are italicized.
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